LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 47 filers reported holding LARIMAR THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,641 | +26.2% | 1,175 | 0.0% | 0.00% | – |
| Q2 2023 | $3,678 | -30.9% | 1,175 | 0.0% | 0.00% | – |
| Q1 2023 | $5,323 | +9.7% | 1,175 | 0.0% | 0.00% | – |
| Q4 2022 | $4,853 | +21.3% | 1,175 | 0.0% | 0.00% | – |
| Q3 2022 | $4,000 | +100.0% | 1,175 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -60.0% | 1,175 | 0.0% | 0.00% | – |
| Q1 2022 | $5,000 | -61.5% | 1,175 | 0.0% | 0.00% | – |
| Q4 2021 | $13,000 | -7.1% | 1,175 | 0.0% | 0.00% | – |
| Q3 2021 | $14,000 | +16.7% | 1,175 | 0.0% | 0.00% | – |
| Q2 2021 | $12,000 | -29.4% | 1,175 | 0.0% | 0.00% | – |
| Q1 2021 | $17,000 | -32.0% | 1,175 | 0.0% | 0.00% | – |
| Q4 2020 | $25,000 | +38.9% | 1,175 | 0.0% | 0.00% | – |
| Q3 2020 | $18,000 | +20.0% | 1,175 | 0.0% | 0.00% | – |
| Q2 2020 | $15,000 | – | 1,175 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 1,515,148 | $22,136,000 | 4.43% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,144,539 | $75,162,000 | 1.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 191,945 | $2,804,000 | 1.53% |
| Atlas Venture Advisors, Inc. | 292,184 | $4,269,000 | 0.79% |
| Sio Capital Management, LLC | 187,223 | $2,735,000 | 0.56% |
| Vivo Capital, LLC | 799,662 | $11,683,000 | 0.41% |
| Altium Capital Management LP | 93,261 | $1,363,000 | 0.38% |
| RA Capital Management | 1,515,151 | $22,136,000 | 0.33% |
| Logos Global Management LP | 230,000 | $3,360,000 | 0.33% |
| DAFNA Capital Management LLC | 81,432 | $1,190,000 | 0.28% |